pMDT in Thoracic Surgery--The Process Implementation Stage

Summary

The risk of acute and chronic pain after thoracic surgery is high. The multi-disciplinary postoperative pain management strategy is the best way to control postoperative pain in thoracic surgery. Through nearly one year of experience in implementation of the pMDT in the thoracic surgery department of Peking University People's Hospital, the investigators have summarized the experience in multidisciplinary pain management and promoted this study in multi-centers across the country, hoping that this study can improve the current situation of acute pain management in patients after thoracic surgery, and at the same time, the deficiencies of this clinical protocol can be found out and improved.

Conditions

• Pain, Postoperative

Interventions

COMBINATION_PRODUCT

pMDT(Process Implementation)

The pMDT(Baseline Investigation) takes multi-model analgesia as the main technical means. Multimodal perioperative analgesia refers to the combination of analgesics, adjuvant drugs and analgesic techniques with different effects throughout the perioperative period to achieve the best curative effect of reducing postoperative acute and chronic pain.

Sponsors & Collaborators

• Peking Union Medical College Hospital

  collaborator OTHER

• Anhui Provincial Hospital

  collaborator OTHER_GOV

• Southwest Hospital, China

  collaborator OTHER

• Fujian Provincial Hospital

  collaborator OTHER

• Hebei Tumor Hospital

  collaborator OTHER

• Qianfoshan Hospital

  collaborator OTHER

• General Hospital of Shenyang Military Region

  collaborator OTHER

• Shanghai Chest Hospital

  collaborator OTHER

• Zhejiang University

  collaborator OTHER

• The First Affiliated Hospital of Zhengzhou University

  collaborator OTHER

• Second Affiliated Hospital of Nanchang University

  collaborator OTHER

• Guangdong Provincial People's Hospital

  collaborator OTHER

• First Affiliated Hospital of Xinjiang Medical University

  collaborator OTHER

• LanZhou University

  collaborator OTHER

• Lanzhou University Second Hospital

  collaborator OTHER

• Kunming General Hospital of PLA

  collaborator UNKNOWN

• Renmin Hospital of Wuhan University

  collaborator OTHER

• Henan Provincial People's Hospital

  collaborator OTHER

• First Affiliated Hospital of Kunming Medical University

  collaborator OTHER

• The People's Hospital of Gaozhou

  collaborator OTHER

• Shaanxi Provincial People's Hospital

  collaborator OTHER

• Liaoning Cancer Hospital & Institute

  collaborator OTHER

• First Affiliated Hospital of Chongqing Medical University

  collaborator OTHER

• Hebei Medical University Fourth Hospital

  collaborator OTHER

• Peking University People's Hospital

  lead OTHER

Principal Investigators

• Feng Yi, MD · Peking University People's Hospital

Eligibility

Min Age

18 Years

Max Age

75 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2018-12-01

Primary Completion

2021-08-31

Completion

2021-08-31

Countries

• China

Study Locations